Relationship between aspirin use after diagnosis of colorectal cancer and patient survival: a meta-analysis of observational studies (Q34658238)

3 August 2017

0 references

Relationship between aspirin use after diagnosis of colorectal cancer and patient survival: a meta-analysis of observational studies (English)

1 reference

3 August 2017

1 reference

1 reference

1 reference

1 reference

1 reference

X-F Ye

1

1 reference

3 August 2017

J Wang

series ordinal

2

1 reference

3 August 2017

W-T Shi

series ordinal

3

1 reference

3 August 2017

J He

series ordinal

4

1 reference

3 August 2017

language of work or name

English

0 references

publication date

2 September 2014

1 reference

British Journal of Cancer

3 August 2017

published in

1 reference

3 August 2017

volume

111

1 reference

3 August 2017

issue

11

1 reference

3 August 2017

page(s)

2172-2179

1 reference

Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

The role of anti-inflammatory drugs in colorectal cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

Clinical pharmacology of non-steroidal anti-inflammatory drugs: a review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

Use of aspirin postdiagnosis improves survival for colon cancer patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

Effect of aspirin and NSAIDs on risk and survival from colorectal cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

Aspirin use and survival after diagnosis of colorectal cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

The secret of immortal time bias in epidemiologic studies.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

Measuring inconsistency in meta-analyses

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

Confounding and indication for treatment in evaluation of drug treatment for hypertension

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260025

Low-dose aspirin use after diagnosis of colorectal cancer does not increase survival: a case-control analysis of a population-based cohort

7 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.481

Incident cancer risk after the start of aspirin use: results from a Dutch population-based cohort study of low dose aspirin users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.481

Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.481

Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.481

21 January 2018

Identifiers

DOI

10.1038/BJC.2014.481

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference